Regulation - Velphoro

Filter

Current filters:

Velphoro

Popular Filters

2332 to 2356 of 2454 results

Australia and New Zealand resurrect plans for joint Therapeutic Products Agency; Medicines Australia views impact

21-06-2011

The governments of Australian and New Zealand have agreed to proceed with a joint scheme for regulation…

Asia-PacificPharmaceuticalRegulation

Pfizer and Acura’s tamper resistant opioid Oxecta gets US FDA approval

21-06-2011

After a significant delay, drugs behemoth Pfizer (NYSE: PFE) and partner Acura Pharmaceuticals (Nasdaq:…

Acura PharmaceuticalsNeurologicalNorth AmericaOxectaPfizerPharmaceuticalRegulationRemoxy

Bristol-Myers Squibb gets EU approval for Nulojix for kidney transplant rejection

21-06-2011

The European Commission yesterday granted marketing authorization for US drug major Bristol-Myers Squibb’s…

Bristol-Myers SquibbEuropeImmunologicalsNulojixPharmaceuticalRegulation

New global strategy to help ensure safety and quality of imported products unveiled by US FDA

21-06-2011

The US Food and Drug Administration has unveiled a new strategy to meet the challenges posed by rapidly…

GlobalMarkets & MarketingNorth AmericaPharmaceuticalRegulation

EMA and US FDA get first parallel QbD application; FDA beats EMA on cancer drug appros

20-06-2011

The European Medicines Agency (EMA) and the US Food and Drug Administration have agreed to accept the…

EuropeNorth AmericaOncologyPfizerPharmaceuticalRegulation

Unanimous FDA advisory support for Regeneron wet-AMD drug Eylea/VEGF Trap-Eye

20-06-2011

As was largely expected following positive briefing papers from the US Food and Drug Administration earlier…

BayerBiotechnologyEyleaOphthalmicsPharmaceuticalRegeneronRegulationVEGF Trap-Eye

Generic drugmakers call to make Europe the “medicines manufacturer of the world”

19-06-2011

The key message delivered at the annual conference of the European Generic medicines Association (EGA)…

EuropeGenericsMarkets & MarketingRegulation

German biotech calls for fair treatment of orphan drugs

17-06-2011

Orphan drugs are a rapidly expanding subsector of the pharmaceuticals industry. Martina Ochel, chief…

BiotechnologyEuropePricingRare diseasesRegulation

ViroPharma's Cinryze cleared for hereditary angioedema in Europe

17-06-2011

The European Commission has granted US biotech firm ViroPharma (Nasdaq: VPHM) Centralized Marketing Authorization…

BiotechnologyCinryzeEuropePharmaceuticalRare diseasesRegulationViroPharma

US FDA approves Bristol-Myers Squibb’s Nulojix for kidney transplant patients

16-06-2011

In a much anticipated move following a positive 13 to five advisory committee vote (The Pharma Letter…

belataceptBristol-Myers SquibbImmunologicalsNorth AmericaNulojixPharmaceuticalRegulation

Bladder cancer risk of Takeda’s Actos now highlighted by US FDA

16-06-2011

The latest bad news for Japan’s largest drugmaker, Takeda Pharmaceutical (TYO: 4502) came last night…

ActosDiabetesNorth AmericaPharmaceuticalRegulationTakeda Pharmaceuticals

China drug formulation market could reach $150 billion by 2015

15-06-2011

It has been well recognized that the drug formulation has been one of the valued-added technologies for…

Asia-PacificGenericsMarkets & MarketingRegulation

New data show young children need higher antibody levels than adults to ensure protection from influenza infections

15-06-2011

A long-standing controversy on the use of influenza vaccines in young children might be coming to an…

PharmaceuticalRegulationVaccines

Dr Reddy’s warned by US FDA over API facility in Mexico

15-06-2011

Indian generic drug major Dr Reddy’s Laboratories (NYSE:RDY) revealed yesterday that its wholly-owned…

Dr Reddy's LaboratoriesGenericsNorth AmericaRegulationSouth America

China SFDA approves new production line for NeoStem’s Suzhau Erye

14-06-2011

There was good news for USA-based NeoStem (NYSE Amex: NBS) yesterday, as China’s medicines regulator…

Asia-PacificBiotechnologyFinancialNeoStemRegulation

Towards updating Israel’s “basket” of health services in 2012

14-06-2011

Towards updating Israel’s “basket” of health services in 2010

HealthcarePharmaceuticalRegulationRest of the World

US FDA warns on risk of more serious forms of prostate cancer with 5-ARI drugs

13-06-2011

The US Food and Drug Administration has warned that the labeling for drugs used to treat enlarged prostate…

AvodartGlaxoSmithKlineMerck & CoNorth AmericaOncologyPharmaceuticalProscarRegulation

GlaxoSmithKline and Valeant get FDA approval for epilepsy drug Potiga

13-06-2011

Following backing from a US Food and Drug Administration advisory panel last summer (The Pharma Letter…

GlaxoSmithKlineNeurologicalNorth AmericaPharmaceuticalPotigaRegulationTrobaltValeant Pharmaceuticals

US FDA working to lessen drug shortage impact

11-06-2011

Last year, the number of drug shortages in the USA reached a record high, and medicine scarcities have…

Markets & MarketingNorth AmericaPharmaceuticalRegulation

France suspends sales of Takeda’s Actos on cancer risk concerns

10-06-2011

Sales of blockbuster diabetes drug Actos (pioglitazone), from Japan’s leading drugmaker Takeda Pharmaceuticals…

ActosDiabetesEli LillyEuropePharmaceuticalRegulationTakeda Pharmaceuticals

2332 to 2356 of 2454 results

Back to top